首页> 美国卫生研究院文献>Infection Chemotherapy >Effectiveness Safety and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus

【2h】

Effectiveness Safety and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus

机译：接受Dolutegravir加Cobicistat加强治疗的Darunavir双重治疗的经验人类免疫缺陷病毒患者的有效性安全性和耐受性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundDual regimen with dolutegravir plus cobicistat-boosted darunavir (DTG/DRV/c) is reasonable alternative option for patients with existing resistance and/or intolerance to nucleoside reverse transcriptase inhibitors (NRTIs).

机译：背景对于患有对核苷类逆转录酶抑制剂（NRTIs）有耐药性和/或耐受性的患者，采用多洛格韦+联合考比司他增强的地那韦（DTG / DRV / c）的双重方案是合理的替代选择。

著录项

期刊名称 Infection Chemotherapy
作者
Sang-Ah Lee; Shin-Woo Kim; Hyun-Ha Chang; Hyejin Jung; Yoonjung Kim; Soyoon Hwang; Sujeong Kim; Han-Ki Park; Jong-Myung Lee;
展开▼
作者单位

展开▼
年(卷),期 2018(50),3
年度 2018
页码 252–262
总页数 11
原文格式 PDF
正文语种
中图分类病毒传染病;
关键词
Dolutegravir Darunavir Cobicistat Human immunodeficiency virus;

机译：Dolutegravir;Darunavir;Cobicistat;人类免疫缺陷病毒;
入库时间 2022-08-17 12:05:38

相似文献

外文文献
中文文献
专利

1. Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients [J] . José Luis Revuelta-Herrero, Esther Chamorro-de-Vega, Carmen Guadalupe Rodríguez-González, The annals of pharmacotherapy . 2018,第1期

机译：治疗切换到DoluteGravir加里林蓟啶双重治疗治疗经验丰富的HIV患者的有效性，安全性和成本
2. Safety, Tolerability, and Efficacy of Generic Dolutegravir-containing Antiretroviral Therapy Regimens Among South Indian Human Immunodeficiency Virus-infected Patients [J] . Kumarasamy Nagalingeswaran, Prabhu Sandeep, Chandrasekaran Ezhilarasi, Clinical infectious diseases . 2019,第6期

机译：含有常规含Dolututgravir的抗逆转录病毒治疗方案在南印度人类免疫缺陷病毒感染患者中的安全性，耐受性和疗效
3. Safety and efficacy of enfuvirtide in combination with darunavir-ritonavir and an optimized background regimen in treatment-experienced human immunodeficiency virus-infected patients: the below the level of quantification study. [J] . DeJesus E, Gottlieb MS, Gathe-JC Jr, Antimicrobial agents and chemotherapy. . 2008,第12期

机译：恩夫韦肽联合达那那韦-利托那韦和优化的背景方案在治疗经验丰富的人类免疫缺陷病毒感染患者中的安全性和有效性：低于定量研究的水平。
4. A Hybrid Classification Tree and Artificial Neural Network Model for Predicting the In vitro Response of the Human Immunodeficiency Virus (HIV1) to Anti-Viral Drug Therapy [C] . W. R. Danter, D. Gregson, K. A. Ferguson, ANNIMAB-1 Conference . 2000

机译：一种混合分类树和人工神经网络模型，用于预测人免疫缺陷病毒（HIV1）对抗病毒药物治疗的体外反应
5. Food safety knowledge of patients who test positive for the human immunodeficiency virus. [D] . Schartzer, Lora L. 2000

机译：对人类免疫缺陷病毒检测呈阳性的患者的食品安全知识。
6. Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study) [O] . Juan Pasquau, Samantha E. de Jesus, Piedad Arazo, 2019

机译：利匹韦林和加强型达那那韦双重治疗对有治疗经验的晚期HIV感染患者的有效性和安全性：24周初步分析（RIDAR研究）
7. Effectiveness, Safety, and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus [O] . Sang-Ah Lee, Shin-Woo Kim, Hyun-Ha Chang, 2018

机译：用DoluteGravir加入携带的人类免疫缺陷病毒治疗患者的DoluteGravir加上钴瘤患者双重治疗的有效性，安全性和可耐受性

Effectiveness Safety and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus

摘要

著录项

相似文献

相关主题

期刊订阅